Virus News and Research

Latest Virus News and Research

Combating monkeypox during COVID-19

Combating monkeypox during COVID-19

Disease ecologist receives $3.5 million to take modeling to the next level with EpiMoRPH

Disease ecologist receives $3.5 million to take modeling to the next level with EpiMoRPH

Research may open door to the design of a better structured rabies vaccine

Research may open door to the design of a better structured rabies vaccine

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

GPR183 gene a novel drug target for severe COVID-19

GPR183 gene a novel drug target for severe COVID-19

HIV coinfection significantly impacts B cell response to SARS-CoV-2

HIV coinfection significantly impacts B cell response to SARS-CoV-2

Co-circulation of respiratory viruses during the SARS-CoV-2 Alpha surge

Co-circulation of respiratory viruses during the SARS-CoV-2 Alpha surge

Glucose meter can detect SARS-CoV-2 antibodies in patient samples

Glucose meter can detect SARS-CoV-2 antibodies in patient samples

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

Type I interferons play crucial role in fending off SARS-CoV-2

Type I interferons play crucial role in fending off SARS-CoV-2

Study underpins use of primary SARS-CoV-2 vaccinations and booster doses during pregnancy

Study underpins use of primary SARS-CoV-2 vaccinations and booster doses during pregnancy

Effectiveness of a hybrid vaccine against COVID-19 and influenza

Effectiveness of a hybrid vaccine against COVID-19 and influenza

At a Bay Area ‘test-to-treat’ site, few takers for free antivirals

At a Bay Area ‘test-to-treat’ site, few takers for free antivirals

Prior spike protein exposures shape protection against SARS-CoV-2 Omicron variant

Prior spike protein exposures shape protection against SARS-CoV-2 Omicron variant

Researchers evaluate artemisinin for COVID-19 management

Researchers evaluate artemisinin for COVID-19 management

Cryo-electron microscopy structure of SARS-CoV-2 membrane protein

Cryo-electron microscopy structure of SARS-CoV-2 membrane protein

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

Nasopharyngeal microbiota influences SARS-CoV-2 infection status and severity

Nasopharyngeal microbiota influences SARS-CoV-2 infection status and severity

Multiomics identifies genomic risk factors for COVID-19

Multiomics identifies genomic risk factors for COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.